TIGIT and cancer: While this reduced responsiveness of TIGIT+ CD56bright ihNK cells could contribute to the tolerogenic immune environment of the liver, it might also represent a disadvantage in the context of infections and cancers, resulting in a “sanctuary compartment” within the liver, as observed in the context of chronic infections with hepatotropic viruses.